An estimated 54 million people suffer from depression in China and the figure is rising. Despite accounting for around 4% of the total population, many sufferers are still not properly diagnosed and/or treated due to a chronic shortage of psychiatrists, while there are only 1.7 physicians per 100,000 people specialized in psychiatric conditions.
Now, one major foreign pharma company is looking to use real world evidence (RWE) to help tackle the issue.




![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

